Latest 10-K

View Latest 10-K

Stock Information

Symbol

Nasdaq: MOTS

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

Motus GI Holdings, Inc. is a medical technology company dedicated to improving endoscopy outcomes and experiences. We are currently focused on bringing to market the Pure-Vu® System which is designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The Pure-Vu® System has the potential to improve the colonoscopy experience for physicians, patients and payers by diminishing the dependency on pre-procedural preparations, thereby enhancing the quality and cost-effectiveness of the exam.

The Pure-Vu® System is a 510(k) US Food and Drug Administration cleared medical device indicated for cleaning a poorly prepped colon during the colonoscopy procedure. The device fits over most standard colonoscopes, allowing the physician to clean poorly-prepped colons in a safe and effective manner to gain clear visualization of the colon mucosa.

Leadership

Our people are our backbone. Touting years of experience in a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Motus GI Holdings, Inc.
1301 E. Broward Blvd.
Suite 310
Fort Lauderdale, FL 33301
T: 954-541-8000
F: 954-541-8265
ir@motusgi.com

Investor Relations

Jenene Thomas Communications, LLC
Jenene Thomas
T: 833-475-8247
mots@jtcir.com

Transfer Agent

Continental Stock Transfer & Trust
1 State Street
30th Floor
New York, NY 10004
T: 800-509-5586
cstmail@continentalstock.com
www.continentalstock.com